
At Mandrixa, we turn commercial uncertainty into clarity.
We’re not just advisors — we take ownership.From launch sequencing to pricing corridors, board alignment to investor readiness, we make commercial decisions happen with confidence and speed.
Commercial Decision Ownership (CDO™): Named owner of key commercial decisions — faster, clearer, board-visible.
Commercial Risk Register (CRR™): Track pricing, HTA, launch readiness, evidence gaps.
Pre-Commercial Audit: Reality check before Phase II/III — avoid strategic dead ends.
Fractional CCO + Embedded PMO: Strategy + execution discipline, with timelines, owners, and dependencies.
Launch Sequencing Simulator: Scenario-based decision framework — US vs EU, orphan vs broad indication, price vs access trade-offs.
Commercial Readiness for Fundraising / Partnering: VC & pharma DD prep, narrative & forecast logic.
Pricing Corridor Ownership: Document defendable pricing ranges and trade-offs.
Commercial Governance Design: Decision rights, escalation logic, board vs management boundaries.
Commercial OKRs for Biotech: Strategy translated into measurable execution metrics.
Commercial Ops-as-a-Service: Ongoing commercial cadence, KPI tracking, cross-functional coordination.
Board Commercial Translator: Translate commercial reality into board-friendly terms.
Commercial Crisis Support (On-Call): Short-term intervention for pricing pushback, failed HTA, or partner hesitation.
Strategy Meets Execution
| Aleksandra Rickman | Simon Rickman |
|---|---|
| CCO | Commercial Ops Lead |
| Leading strategy, decisions, and board alignment. | Ensuring execution is seamless, predictable, and stress-free. |
Together, we cover strategy and operations as one integrated commercial powerhouse, ensuring ideas translate into results — no gaps, no guesswork.
Ready to move from strategy to execution? Reach out via LinkedIn or schedule a conversation. We share insights, articles, and commercial best practices on our LinkedIn page.